More Than One in Four Adults Eligible for GLP-1 Receptor Agonists

WEDNESDAY, Jan. 14, 2026-- More than one-quarter of adults aged 25 to 64 years from 99 countries are eligible to receive a glucagon-like peptide-1 (GLP-1) receptor agonist, according to a research letter published in the February issue of The...